HUTCHMED (China) Limited (HK:0013) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HUTCHMED (China) Limited has announced its blocklisting six monthly return, highlighting that during the period from June to December 2024, 241,375 ordinary shares were issued under the 2015 Share Option Scheme. The company, known for its innovative cancer and immunology therapies, maintains a robust pipeline with 871,601,095 shares currently in issue.
For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.